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Background
Flavonoids are well known for their vasodilatation activ-
ity. Their mechanism of action is still to be elucidated.
Bilitranslocase is a bilirubin-specific membrane carrier
that is also responsible for the ATP-independent transport
of flavonoids across the cell membrane [1]. Recently, the
expression of bilitranslocase in the endothelium has been
characterized [2]. The aim of the study was to examine the
possible role of bilitranslocase in the vasodilatation activ-
ity of flavonoids. As a source of flavonoids we used bilber-
ries, which are abundant in anthocyanins that show
strong affinity for bilitranslocase.
Methods
A bilberry extract, of which the anthocyanin content was
quantified by HPLC-DAD analysis, was used. Anthocy-
anins were expressed as a standard of cyanidin 3-glucoside
(mg/L). Thoracic aortic rings obtained from male Wistar
rats were mounted in standard organ baths filled with
Krebs-Henseleit solution, maintained at 37°C with a 95%
O2  / 5% CO2  mixture. Rings were divided into four
groups: control group (intact aortic rings), endothelium
denuded rings, rings with nitric oxide synthase (NOS)
activity inhibited by application of L-NNA (0.1 mmol/L)
and rings with inhibited bilitranslocase-mediated mem-
brane transport. In the last group, aortic rings were pre-
incubated for 30 min with mono-specific polyclonal
bilitranslocase antibodies (0.24 μg/mL). After inducing
submaximal contraction (60 mmol/L KCl) in all studied
groups, a chemically characterized bilberry extract was
applied in increasing concentrations (0.5-20 mg/L). Vas-
cular tone was measured isometrically by a mechano-elec-
trical transducer. Further tests were done to check the
expression of bilitranslocase in the vascular system
(endothelial cell line EA.hy 926 and vascular smooth
muscle cell line A7r5) by Western blot analysis using
bilitranslocase antibodies.
Results
Western blot analysis showed the presence of bilitranslo-
case on both endothelial and smooth muscle cells. Bil-
berry extract relaxed aortic rings in a concentration-
dependent manner in the control group, but neither in
endothelium-denuded aortic rings nor in rings with
inhibited NOS. The maximum relaxation (19.00 ± 2.01%,
n = 5) observed at 20 mg/L in the group with inhibited
bilitranslocase activity was significantly lower (p < 0.001)
compared to the control group (34.95 ± 3.11%, n = 10).
Conclusion
Our results show that the vasodilatation activity of
anthocyanins in bilberry extract is partly dependent on
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the bilitranslocase-mediated transport of flavonoids into
the endothelium, followed by the activation of NOS.
However, even though the bilitranslocase is also
expressed on smooth muscle cells, its role in the vasodila-
tation activity on these cells remains negligible.
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